A Feasibility Registry of Actigraphy Monitoring in Degenerative Mitral Regurgitation Subjects Receiving the MitraClip® Device

Stopped early

Conditions studied: Mitral Regurgitation

In brief

A prospective, open-label, and multi-centered feasibility registry.

Key facts

Study ID

NCT02858245

Run by

Abbott Medical Devices

People needed

30

Starts

2016-11-01

Expected to finish

2017-12-01

Last updated by the study team

2018-05-07

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subject must consent to receiving the MitraClip device
• Subject must consent, be able, and commit to wearing the Actiwatch continuously for approximately 7 months
• Subject must consent to use of their data from this registry for purposes of exploratory research and publication and presentation

You may not qualify if…

• Subject is not a member of vulnerable population
• Subject must not have any disabilities that preclude reliable data collection from the Actiwatch, e.g., epilepsy with uncontrolled recurring episodes, serious stage degenerative/disabling disease (e.g. Parkinson's disease), inability to walk or will require walking aids, etc.

Where it is running

• Banner University Medical Center — Phoenix, Arizona, United States
• Cedars-Sinai Medical Center — Los Angeles, California, United States
• University of Colorado Hospital — Aurora, Colorado, United States
• Baptist Hospital of Miami — Miami, Florida, United States
• Mayo Foundation for Medical Education and Research — Rochester, Minnesota, United States
• Carolinas Medical Center — Charlotte, North Carolina, United States
• The Cleveland Clinic Foundation — Cleveland, Ohio, United States
• Bon Secours St Mary's Hospital — Richmond, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.